EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Mid-term objective results of a randomized clinical trial: Fractional carbon dioxide vs sham laser for genitourinary syndrome of menopause on breast cancer survivors using aromatase inhibitors

E. Mension, A. Immaculada, R.T. Laura, C. Natalia, A. Silvia, A.A. Sonia, C.B. Camil

European Journal of Cancer · 2026-03 · 237 · 116332

DOI: 10.1016/j.ejca.2026.116332 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Cancer, 2026-03. Verfasst von E. Mension und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Mension, E., Immaculada, A., Laura, R., Natalia, C., Silvia, A., Sonia, A., & Camil, C. (2026). Mid-term objective results of a randomized clinical trial: Fractional carbon dioxide vs sham laser for genitourinary syndrome of menopause on breast cancer survivors using aromatase inhibitors. European Journal of Cancer, 237, 116332. https://doi.org/10.1016/j.ejca.2026.116332

Vancouver

Mension E, Immaculada A, Laura R, Natalia C, Silvia A, Sonia A, et al. Mid-term objective results of a randomized clinical trial: Fractional carbon dioxide vs sham laser for genitourinary syndrome of menopause on breast cancer survivors using aromatase inhibitors. European Journal of Cancer. 2026;237:116332. doi:10.1016/j.ejca.2026.116332

BibTeX
@article{Mension2026,
  author = {Mension, E. and Immaculada, A. and Laura, R.T. and Natalia, C. and Silvia, A. and Sonia, A.A. and Camil, C.B.},
  title = {Mid-term objective results of a randomized clinical trial: Fractional carbon dioxide vs sham laser for genitourinary syndrome of menopause on breast cancer survivors using aromatase inhibitors},
  journal = {European Journal of Cancer},
  year = {2026},
  volume = {237},
  pages = {116332},
  doi = {10.1016/j.ejca.2026.116332}
}
Kostenlos starten →